T-cell immunoglobulin mucin molecule-3, transformation growth factor β, and chemokine-12 and the prognostic status of diffuse large B-cell lymphoma

doi:10.12998/wjcc.v10.i32.11804

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1739)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

WORD

HTML

923

Tables (1-4)

214

Sum=1264

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

144

Download

331

Sum=475

Nov 16, 2022 (publication date) through May 5, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. Nov 16, 2022; 10(32): 11804-11811
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11804

Table 1 Comparison of T-cell immunoglobulin mucin molecule-3, transforming growth factor β, and chemokine 12 expression between cancerous and adjacent tissues, n (%)

Groups	Tim-3 positive	TGF-β positive	CXCL12 positive
DLBCL group (n = 97)	73 (75.26)	51 (52.58)	82 (84.54)
Control group (n = 93)	36 (38.71)	23 (24.73)	27 (29.03)
χ² value	25.931	15.483	59.806
P value	0.000	0.000	0.000

DLBCL: Diffuse large B-cell lymphoma; Tim-3: T-cell immunoglobulin mucin molecule-3; TGF-β: Transforming growth factor β; CXCL12: Chemokine 12.

Citation: Wu H, Sun HC, Ouyang GF. T-cell immunoglobulin mucin molecule-3, transformation growth factor β, and chemokine-12 and the prognostic status of diffuse large B-cell lymphoma. World J Clin Cases 2022; 10(32): 11804-11811
URL: https://www.wjgnet.com/2307-8960/full/v10/i32/11804.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i32.11804